The Ensign Group Inc. Common Stock (ENSG) fair value

ACCE thesis

The Ensign Group operates skilled nursing facilities, senior living communities and home health and hospice agencies, mostly through a decentralized model in which local operators run their own buildings under a common clinical and financial framework. Its moat is the ability to take over underperforming facilities, often from distressed or unwilling operators, and bring them to profitability, which has let it grow through acquisition without the cost discipline of a typical roll-up. The near-term driver is Medicare and Medicaid reimbursement for post-acute care, where the company has been growing revenue 17.3% year on year while trading at a forward P/E of 20.7 against a trailing 27.2, implying the market expects earnings to expand as the acquired portfolio matures. The 9.0% operating margin and 17.0% ROE are respectable for a labor-heavy business, but staffing costs and government rate-setting remain the key risks to whether that spread holds. Not in any major index, which is itself a reason to check whether the thesis is being overlooked or simply too small and too reimbursement-dependent to attract institutional ownership.